BHRB NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Burke & Herbert Financial Services Corp. Common Stock · Financial Services · Banks - Regional

Open interactive chart View report data Download investor PDF
Latest close 70.47 USD
-1.5% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 8.6% above the Trend Line and sits at 83.5% of its 52-week range. The latest completed week returned -1.5%, after a -1.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 56/100. Near-term considerations: volume confirmation is below normal; earnings are due in 84d.

Setup score 57 out of 100
Latest Close 70.47 USD 24 Jul 2026
1W Return -1.5% latest completed week
4W Return -1.2% short-term follow-through
12W Return 10.0% quarterly tape
Trend Breadth 75.0% 39 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 43.45% based on similar historical setup states.
  • 1 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.5% Latest completed week; four-week move -1.2%. Indicator stack 59/68 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.45% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 56/100 75 relevant articles in the latest sentiment read. Event risk 84d Next report is scheduled for 22 Oct 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 8.6% above the Trend Line and sits at 83.5% of its 52-week range. The latest completed week returned -1.5%, after a -1.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6812-week average 0.45

12-week confirmation

Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.68Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers

No recent accumulation markers. 1 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -1.2% over four weeks, 10.0% over 12 weeks, and 16.1% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W-1.5%
4W-1.2%
12W10.0%
26W12.0%
52W16.1%
Active trend streak5 weeks
Active weeks in one year39
Trend breadth75.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.05Latest activity-pressure read.
Pressure change-14.2%Four-week change in activity pressure.
Leadership2.45Latest relative-leadership reading.
RS change878.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 100% Model confidence 100%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength86/100Blend of value, momentum, and quality. Underlying universe rank 15; rank 1 is best.
Value72/100Relative valuation strength. Underlying universe rank 29; rank 1 is best.
Quality73/100Profitability and accounting quality. Underlying universe rank 28; rank 1 is best.
Momentum68/100Medium-term price momentum. Underlying universe rank 33; rank 1 is best.
Growth25/100Revenue and earnings growth. Underlying universe rank 76; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework42/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
14.6x
Price divided by trailing earnings.
Price / sales
3.2x
Market value relative to trailing revenue.
EV / EBITDA
14.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
68.1%
Gross profit retained from each unit of revenue.
Operating margin
27.1%
Operating profit retained from revenue.
Free-cash-flow margin
27.0%
Free cash flow generated from revenue.
Return on invested capital
6.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-10.1%
Latest one-year revenue growth.
EPS growth
-7.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
3.1%
Cash dividends relative to market value.
Buyback yield
-0.0%
Net share repurchases relative to market value.
Shareholder yield
3.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment56/100

Weighted news tone is neutral across 75 relevant articles.

22 positive · 50 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings84dNext report is scheduled for 22 Oct 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-4.4%Distance below the 52-week high.
13-week volatility3.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+8.9%Week of 26 Jun.
Worst week-5.2%Week of 27 Feb.
Latest week-1.5%Week of 24 Jul.

Shape of recent returns

Strong gains4
Modest gains10
Flat weeks0
Modest losses11
Sharp losses1
Recent vol3.0%13-week weekly-return volatility.
Base vol3.5%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew3.0% / -2.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape58/100

Trend, activity pressure, participation, and risk combine to a 58/100 tape read.

 Indicator analysis49/100

Latest 12-week confirmation: trend 6/12, activity pressure 8/12, relative leadership 2/12.

Activity pressure 0.68; 1 reversal markers Next-Week ExpectancyNegative 43.45%

Next-week expectancy is negative with a 43.45% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors74/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 68; Small Cap Core rank 40 SVQF42/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 424.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment56/100

Weighted news tone is neutral across 75 relevant articles.

Citizens Financial Group, Inc. (CFG) Stock Price, News, Quote & History Insiders50/100

No recent insider transaction evidence is stored.

 Earnings84d

Next report is scheduled for 22 Oct 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202670.47 USD-1.5%64.90 USD56.50 USD1.052.45547.6KOn
17 Jul 202671.54 USD1.8%64.62 USD56.34 USD1.342.25795.5KOn
10 Jul 202670.30 USD0.2%64.40 USD56.18 USD1.31-3.85762.4KOn
3 Jul 202670.15 USD-1.7%64.33 USD56.02 USD1.37-2.58815.6KOn
26 Jun 202671.34 USD8.9%64.18 USD55.91 USD1.23-0.311.5MOn
19 Jun 202665.51 USD-2.3%63.94 USD55.82 USD0.63-12.65938.1KOff
12 Jun 202667.08 USD4.0%63.83 USD55.84 USD0.34-8.44989.2KOff
5 Jun 202664.49 USD1.4%63.60 USD55.87 USD-0.16-10.141.2MOff
29 May 202663.60 USD1.3%63.41 USD55.92 USD-0.40-15.59507.6KOff
22 May 202662.77 USD2.1%63.21 USD55.98 USD-0.21-14.60910.9KOff
15 May 202661.47 USD-2.8%63.12 USD56.06 USD-0.22-15.64717.4KOff
8 May 202663.25 USD-1.3%62.98 USD56.11 USD0.08-13.80616.6KOn
1 May 202664.07 USD1.1%62.74 USD56.14 USD0.22-8.28831.7KOn
24 Apr 202663.39 USD-3.5%62.56 USD56.18 USD-0.01-8.14585.1KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.